Harnessing technology across RELX
Around 8,000 technologists, half of whom are software engineers, work at RELX. Annually, the company spends $1.4bn on technology. The combination of our rich data assets, technology infrastructure and knowledge of how to use next generation technologies, such as machine learning and natural language processing, allows us to create effective solutions for our customers. Helping research chemists with Elsevier's Reaxys Reaxys enables the shortest path to chemistry research answers, supporting the early stages of drug development in the pharmaceutical industry, exploratory chemistry research in academia, and product development in industries such as chemicals and oil & gas. The amount of chemical information published each year is increasing exponentially, making it more and more challenging for research chemists to quickly find targeted and actionable information to help support their research.
Jun-21-2019, 02:45:07 GMT
- Country:
- North America > United States (0.06)
- Industry:
- Health & Medicine > Pharmaceuticals & Biotechnology (1.00)
- Law (1.00)
- Technology: